Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intermagnetics (IMG) -- Ignore unavailable to you. Want to Upgrade?

To: rustyjack who wrote (2505)	3/12/1998 10:44:00 PM
From: Mark Shaw	Read Replies (1) \| Respond to of 3448

I listened to the call as well, Ron. I was equally unimpressed. I thought they were very non-committal about FRIGC. That stuff about distributors waiting until May to sign up is non-sense. If they were going to carry the product at all they would have signed on by now. They might not have bought a lot but they still would have been on board. In fact, I'm kind of surprised by the recent run-up. I was expecting a big announcement from one of their product areas. As you noticed, earnings merely met expectations and wouldn't even have done that without acquisitions. I wouldn't be totally shocked to see this thing drift back down to between 8 and 9. I think FRIGC is a flop and the HTS stuff is still 3-5 years away from commercialization. I almost fell asleep toward the end of that conference call.

To: rustyjack who wrote (2505)	3/13/1998 12:47:00 PM
From: Greg Werlinich	Respond to of 3448

I'm glad that everyone listened to the call. It saved me time trying to transcribe my notes. I was equally unimpressed, although at least there was no bad news. Nothing to knock the stock down. I think we'll see it trade in the $10-$12 range for a bit, at least until the CERN announcement comes. Then we wait until news of Q4 starts rolling in. The fact that gross margins continue to improve was positive. I also think there is upside potential for the Trex Medical relationship. I also would not be surprised to hear of further acquisitions in the coming months. They have had good success with the two done so far. This is one way to stimulate growth while you wait for parts of your core business to recover. Done at the right price, it's a good strategy. Greg